A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Clinical trial NCT05163808 · COMPLETED

Trial details

NCT number: NCT05163808
Sponsor: Tetra Discovery Partners
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2022-03-29
Primary completion: 2025-09-02
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.